@article{870234ea948244298cd9d65d03314cb9,
title = "Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant",
abstract = "The anti-IL1 drug canakinumab has been administered in a patient with a high-penetrance T50M TNFRSF1A variant: this experience has been discussed in this manuscript.",
keywords = "Autoinflammation, Autoinflammation",
author = "Luca Cantarini and Giuseppe Lopalco and Antonio Vitale and Francesco Caso and Giovanni Lapadula and Florenzo Iannone and Mauro Galeazzi and Donato Rigante",
year = "2015",
doi = "10.1111/1756-185X.12521",
language = "English",
volume = "18",
pages = "473--475",
journal = "International Journal of Rheumatic Diseases",
issn = "1756-185X",
publisher = "John Wiley and Sons Inc.",
}